TandemAI gets rolling with $35m in financing
The Chinese company is working on a drug discovery platform utilizing AI, and managed to secure funds to progress its business.
The Chinese company is working on a drug discovery platform utilizing AI, and managed to secure funds to progress its business.
The company acquires Cromsource, which is a CRO focused on the US and European markets.
A clinical trial travel solution that can remove administrative burdens for research sites and eliminate logistical and financial barriers for participants has significantly expanded.